Serum biomarkers of brain injury after uncomplicated cardiac surgery: Secondary analysis from a randomized trial.

"CONFLICTS OF INTEREST Dr. Zetterberg is a Wallenberg Scholar supported by grants from the Swedish Research Council (#2018‐02532), the European Research Council (#681712), Swedish State Support for Clinical Research (#ALFGBG‐720931), the Alzheimer Drug Discovery Foundation (ADDF), USA (#201809‐2016862), the AD Strategic Fund and the Alzheimer's Association (#ADSF‐21–831376‐C, #ADSF‐21–831381‐C and #ADSF‐21–831377‐C), the Olav Thon Foundation, the Erling‐Persson Family Foundation, Stiftelsen för Gamla Tjänarinnor, Hjärnfonden, Sweden (#FO2019‐0228), the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska‐Curie grant agreement No. 860197 (MIRIADE), and the UK Dementia Research Institute at UCL, London. Dr. Blennow is supported by the Swedish Research Council (#2017‐00915), the Alzheimer Drug Discovery Foundation (ADDF), USA (#RDAPB‐201809‐2016615), the Swedish Alzheimer Foundation (#AF‐742881), Hjärnfonden, Sweden (#FO2017‐0243), the Swedish state under the ALF agreement between the Swedish government and the County Councils (#ALFGBG‐715986), and the European Union Joint Program for Neurodegenerative Disorders (JPND2019‐466‐236). Dr. Jeppsson has received honorarium for consultancy from Xvivo Perfusion. Otherwise, none of the authors report any conflict of interests."

"Funding information"

"The study was performed in accordance with the Declaration of Helsinki and approved by the Regional Research Ethics Committee in Gothenburg (entry number: T 847–16 Ad 1003–15). Written informed consent was obtained from all subjects. The study was registered at ClinicalTrials.gov prior to enrolment (identifier: NCT02767154)."